Blog post
Ever since carfilzomib, made by ONYX Pharmaceuticals, began progressing through the clinical trials process from Phase I forward, it has been a regular topic of interest on the IMF Hotline. The recent…
Blog post
Quantum Effects in DNA: What They Could Mean for Cancer Research Reading about the newly re-discovered Rainbow Toad in Borneo reminded me of my January 27,…
Blog post
Exploring Innovative Approaches in the Quest for a Myeloma Cure
At this month's Patient & Family Seminar in Dallas, TX, I posed this question to the panel of myeloma experts: "What myeloma…
Videos
DOWNLOAD SLIDES
Page
CAR T-Cell Therapy for Myeloma: Overview and BenefitsChimeric antigen receptor (CAR) T-Cell therapy is a cutting-edge, personalized treatment for myeloma that uses your own T-cells to target cancer. The process involves collecting and modifying your T-cells, followed by infusion and close…
Event
Register NOW for the FREE IMF Virtual Myeloma Community Workshop August 24, 20263:00 PM PT / 4:00 PM MT5:00 PM CT / 6:00PM ET The Virtual Myeloma Community Workshop will focus on topics concerning relapsed/refractory myeloma patients. Learn more about treatment response, disease…
Videos
Can CAR-T Replace Stem Cell Transplant? Myeloma Questions on Cure, GLP-1s & Risk AnsweredCan CAR T-cell therapy replace stem cell transplant in multiple myeloma? Does bispecific therapy before CAR-T make it less effective? Are GLP-1 weight loss drugs safe for myeloma patients, and does 10 years…
News Article
Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research 3rd Annual Iceland Cycling Expedition from August 18-24, 2026, Aims to Fund Myeloma Prevention and a Cure STUDIO…
News Article
Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month Myeloma Action Month Global Campaign Celebrated Resilience, Strengthened Connections, and Inspired Hope in 96 Countries STUDIO CITY, CA, April 9, 2026 — As this year’s Myeloma…
Videos
Is Dex Really Necessary? CAR T, Bispecifics & Myeloma Questions Answered | QA ReplayCan you still get CAR T if you live alone? Can pomalidomide be given at a lower dose? Is dexamethasone still really necessary? In this multiple myeloma Facebook Live, Dr. Joseph Mikhael and Dr. Melissa…
Author
Vice Chairperson of the Board | Medical ProfessionalDr. Sagar Lonial is Professor and Chair of the Department of Hematology and Medical Oncology at the Emory University School of Medicine. He is the Chief Medical Officer of the Winship Cancer Institute at Emory University and is internationally…
Videos
CAR T, Clinical Trials & the Future of Myeloma Treatment | Multiple Myeloma Q&ACan Multiple Myeloma Be Cured? How Long Can Remission Last Today? Dr. Sagar Lonial Answers Your Questions Dr. Sagar Lonial explains how modern treatments like CAR T-cell therapy and bispecific antibodies are…
Videos
Just Diagnosed With Multiple Myeloma? Ask Your Doctor These 3 Questions (In 60 Seconds)Just diagnosed with multiple myeloma and not sure what to ask your doctor? In this quick video, Dr. Joseph Mikhael from the International Myeloma Foundation shares the three most important questions every newly…
News Article
Dr. Joseph Mikhael Steps into New Role as Medical Advisor for the International Myeloma Foundation STUDIO CITY, CA, April 2, 2026 — The International Myeloma Foundation (IMF) today announced that Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO has taken the step of transitioning…
News Article
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) is recommending the approval of Sarclisa (isatuximab) as a subcutaneous formulation administered via on-body injector for myeloma patients. On Friday, March 27, Sanofi announced via press release that "…
News Article
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has approved Darzalex® (daratumumab) for a Type II variation labeling, which allows myeloma patients or their caregivers to administer the drug from the fifth dose, "if determined to be appropriate by…
News Article
In this episode of OncoDaily, host Shushan Hovsepyan speaks with Heather Cooper Ortner, President and CEO of the International Myeloma Foundation, about the global effort to advance multiple myeloma…
Videos
MGUS, High-Risk Myeloma, Relapse & Dexamethasone Side Effects | Your Questions AnsweredDoes multiple myeloma come back more aggressively each time? What does it mean to have MGUS? How do you know if myeloma is high risk, and what side effects can dexamethasone cause? In this Q&A, Dr.…